ORAI1 and cancer: A decrease of extracellular Ca2+ concentrations or partial inhibition of ORAI1 activity by selective blockers in the TME could obviously inhibit cancer growth by simultaneously increasing cytotoxic T Lymphocytes and natural killer cell cytotoxicity and decreasing cancer cell proliferation.